Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name SNHG16
   Synonyms SNHG16, Nbla10727, Nbla12061, ncRAN
   Region GRCh38_17:76557766-76565348    Sequence
   Ensembl ENSG00000163597
   RefSeq NR_038108
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name ovarian cancer
   ICD-0-3 C56.9  
   Methods qPCR, Western blot, in vitro knockdown
   Sample tumor tissues, ovarian cancer cells (SKOV-3, ES2, HO8910, OMC685)
   Expression Pattern up-regulated
   Function Description

the expression of SNHG16 in ovarian cancer was significantly higher than that in normal tissues, and the difference was statistically significant. Compared with patients with lower expression of SNHG16, patients with higher expression of SNHG16 had higher tumor stage, high rate of distant metastasis and low overall survival rate. Compared with the negative control si-NC group, the cell proliferation, invasion and migration ability in SNHG16 knockdown group (si-SNHG16) significantly decreased. Western Blot showed that after knockdown of SNHG16, expressions of P-AKT and MMP9 decreased significantly, while there was no significant change in the total AKT level.

   Pubmed ID 29461589
   Year 2018
   Title Long non-coding RNA SNHG16 promotes cell growth and metastasis in ovarian cancer.
   External Links
   Links for  SNHG16 GenBank       HGNC       lncrnadb       Noncode
   Links for  ovarian cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.